Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections in Pediatric AML Patients
NCT07022678Phase 3Recruiting
- Sponsor
- Children's Oncology Group
- Start
- Aug 2026
- Primary completion
- Jan 2032
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of xylitol in bloodstream infection (BSI), sponsored by Children's Oncology Group. Started Aug 2026; status: recruiting.
02
Drugs
xylitol
03
Conditions
bloodstream infection (BSI)
Beyond the preview
Go deeper on NCT07022678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07022678.